Condition |
Patients |
Antibiotic |
Intervention |
Control |
Outcome |
Author [reference] Country Year |
Respiratory infections |
|
|
|
|
|
|
Community acquired pneumonia |
Adult inpatients without immunosuppression, recent hospitalization or antibiotic use |
Physician choice |
Median 5 days (minimum 5 days, afebrile >48 h and clinically stable) |
Median 10 days (clinician discretion) |
Noninferior |
Uranga [23] Spain 2016 |
Community acquired pneumonia |
Nonpregnant adult in-patients with mild–moderate pneumonia and no significant comorbid illness |
Levofloxacin |
750 mg daily for 5 days (mean 4.86 days) |
500 mg daily for 7–14 days (mean 10.35 days) |
Noninferior |
Zhao [20] China 2016 |
Streptococcal pharyngitis and tonsillitis |
Adult patients with a positive rapid antigen test for group A streptococcus and 3 or more Centor criteria |
Penicillin V |
800 mg 6-hourly for 5 days |
1000 mg 8-hourly for 10 days |
Noninferior |
Skoog Ståhlgren [27] Sweden 2019 |
Systemic infection |
|
|
|
|
|
|
Gram-negative sepsis |
Adult inpatients with source control, no fever for 48 h and no haemodynamic instability |
Physician choice |
7 days |
14 days |
Noninferior |
Yahav [8] Israel 2019 |
Febrile neutropaenia |
Adult haematology patients with high-risk febrile neutropaenia (expected neutropenia of ≤0.5 × 109 cells/l for ≥7 days) |
Empiric therapy consistent with local guidelines |
Mean 16.1 antibiotic-free days of 28 (treatment until afebrile for 72 h + resolved signs of infection regardless of neutrophil count) |
Mean 13.6 antibiotic-free days of 28 (treatment until afebrile for 72 h + resolved signs of infection + neutrophils >0.5 × 109cells/l) |
Reduced antibiotic exposure without difference in adverse events or mortality |
Aguilar-Guisado [15] Spain 2017 |
Skin and soft tissue |
|
|
|
|
|
|
Severe cellulitisa |
Adults inpatients. Exclusions include neutropaenia, cirrhosis, necrotising fasciitis and severe peripheral vascular disease |
Flucloxacillin |
6 days |
12 days |
Noninferiority could not be demonstrated. Participants with a 6-day course of antibiotic therapy had more frequent relapse and hospital readmission |
Cranendonk [48] Netherlands 2020 |
Intraabdominal infections |
|
|
|
|
|
|
Uncomplicated diverticulitisb |
Adult patients presenting with CT-verified right colonic uncomplicated diverticulitis |
Cefmetazole + metronidazole |
One day |
Four days |
Noninferior with significantly shorter hospital length of stay |
Park [56] South Korea 2019 |
Appendicitisb |
Adult patients presenting with CT-verified uncomplicated appendicitis |
Cefmetazole |
Zero days |
Four days |
No difference in initial treatment failure or recurrence however study underpowered |
Park [33] South Korea 2017 |
Complicated appendicitisc |
Adult patients undergoing surgery for acute complicated appendicitis |
Amoxicillin/clavulanate OR ampicillin/sulbactam |
One day |
Mean 6 days (clinician discretion) |
No difference in complications or readmission rates however study underpowered |
Saar [32] Estonia 2018 |
Intraabdominal sepsis |
Adult inpatients with complicated intraabdominal infection following procedure for source control |
Physician choice if consistent with local guidelines |
Median 4 days (fixed duration) |
Median 8 days (treatment for 2 days after resolution SIRS) |
No difference in outcomes with a shorter fixed duration however target enrolment not reached because of loss of funding |
Sawyer [30] USA 2015 |
Intraabdominal sepsis in critically ill ICU patients |
Adult ICU patients with postoperative intraabdominal infection and adequate source control |
Physician choice |
8 days |
15 days |
No significant difference in mortality, relapse or length of stay. Increase in percutaneous drainage procedures in intervention group |
Montravers [31] France 2018 |
Bone and joint |
|
|
|
|
|
|
Vertebral osteomyelitis |
Nonpregnant adult patients with bacterial verterbral osteomyelitis, no prosthesis in situ, and life-expectancy >1 year |
Physician choice in accordance with French guidelines |
6 weeks |
12 weeks |
Noninferior (however did not meet noninferiority criteria in all subgroups) |
Bernard [44] France 2015 |
Septic arthritisc |
Adult inpatients with native joint septic arthritis who underwent surgical washout; two-thirds hand or wrist; one-third large joint |
Physician choice |
2 weeks |
4 weeks |
Noninferior with significantly shorter hospital length of stay |
Gjika [43] Switzerland 2019 |
Urinary tract infections |
|
|
|
|
|
|
Cystitis |
Nonpregnant females >20 years of age presenting with symptoms of cystitis without fever |
Cefditoren 100 mg 8-hourly |
3 days |
7 days |
No statistically significant difference between clinical or microbiological end points for the two groups however study underpowered |
Sadahira [36] Japan 2017 |
Acute complicated urinary tract infection |
Nonpregnant adult patients with fever and urinary tract infection. Patients with significant renal disease or renal transplant excluded |
Physician choice of IV therapy followed by oral ciprofloxacin 500 mg 12-hourly |
7 days |
14 days |
Noninferior in female participants. Inferior in male participants with short-term cure 86 versus 98% |
Van Nieuwkoop [39] Netherlands 2017 |
Acute complicated urinary tract infection |
Nonpregnant adult female outpatients with urinary tract infection and fever. Patients with immunosuppression, urinary tract prosthetic material or abnormalities excluded |
Ofloxacin 200 mg 12-hourly OR levofloxacin 500 mg 6-hourly |
5 days |
10 days |
Trial prematurely stopped because of unexpectedly high rates of fluoroquinolone resistance (9%) and loss to follow up (45%) before final review |
Dinh [41] France 2017 |
Pyelonephritisc |
Nonpregnant adult inpatients who are clinically stable by day 7. In a setting with high rates of antibiotic resistant gram-negatives |
Physician choice of nonfluoroquinolone therapy (76% amikacin-containing regimen) |
7 days |
14 days |
Noninferior with significantly shorter hospital length of stay. |
Rudrabhatia [40] India 2018 |
Comments